Cargando…
Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes
Adoptive immunotherapy with Tregs is a promising approach for prevention or treatment of type 1 diabetes. Islet antigen-specific Tregs have more potent therapeutic effects than polyclonal cells, but their low frequency is a barrier for clinical application. To generate Tregs that recognize islet ant...
Autores principales: | Spanier, Justin A., Fung, Vivian, Wardell, Christine M., Alkhatib, Mohannad H., Chen, Yixin, Swanson, Linnea A., Dwyer, Alexander J., Weno, Matthew E., Silva, Nubia, Mitchell, Jason S., Orban, Paul C., Mojibian, Majid, Verchere, C. Bruce, Fife, Brian T., Levings, Megan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980092/ https://www.ncbi.nlm.nih.gov/pubmed/36865264 http://dx.doi.org/10.1101/2023.02.23.529737 |
Ejemplares similares
-
Tregs with an MHC class II peptide–specific chimeric antigen receptor prevent autoimmune diabetes in mice
por: Spanier, Justin A., et al.
Publicado: (2023) -
Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection
por: Rosado-Sánchez, Isaac, et al.
Publicado: (2023) -
Enhanced CD4(+) and CD8(+) T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses
por: Dwyer, Alexander J., et al.
Publicado: (2021) -
T reg–specific insulin receptor deletion prevents diet-induced and age-associated metabolic syndrome
por: Wu, Dan, et al.
Publicado: (2020) -
Human A2-CAR T cells reject HLA-A2+ human islets transplanted into mice without inducing graft versus host disease
por: Ellis, Cara E., et al.
Publicado: (2023)